- Home
- DNTH vs RPAY Comparison
DNTH vs RPAY Comparison
Compare DNTH & RPAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- RPAY
- Stock Information
- Founded
- DNTH 2015
- RPAY 2006
- Country
- DNTH United States
- RPAY United States
- Employees
- DNTH N/A
- RPAY N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- RPAY Business Services
- Sector
- DNTH Health Care
- RPAY Consumer Discretionary
- Exchange
- DNTH Nasdaq
- RPAY Nasdaq
- Market Cap
- DNTH 670.7M
- RPAY 665.4M
- IPO Year
- DNTH N/A
- RPAY N/A
- Fundamental
- Price
- DNTH $22.29
- RPAY $7.46
- Analyst Decision
- DNTH Strong Buy
- RPAY Strong Buy
- Analyst Count
- DNTH 9
- RPAY 6
- Target Price
- DNTH $46.43
- RPAY $12.33
- AVG Volume (30 Days)
- DNTH 245.5K
- RPAY 428.8K
- Earning Date
- DNTH 03-20-2025
- RPAY 02-27-2025
- Dividend Yield
- DNTH N/A
- RPAY N/A
- EPS Growth
- DNTH N/A
- RPAY N/A
- EPS
- DNTH N/A
- RPAY N/A
- Revenue
- DNTH $5,366,000.00
- RPAY $310,758,000.00
- Revenue This Year
- DNTH $100.14
- RPAY $9.03
- Revenue Next Year
- DNTH N/A
- RPAY $5.59
- P/E Ratio
- DNTH N/A
- RPAY N/A
- Revenue Growth
- DNTH 51.41
- RPAY 5.95
- 52 Week Low
- DNTH $18.35
- RPAY $7.15
- 52 Week High
- DNTH $33.77
- RPAY $11.27
- Technical
- Relative Strength Index (RSI)
- DNTH 49.77
- RPAY 45.39
- Support Level
- DNTH $21.28
- RPAY $7.28
- Resistance Level
- DNTH $23.28
- RPAY $7.75
- Average True Range (ATR)
- DNTH 1.75
- RPAY 0.21
- MACD
- DNTH 0.17
- RPAY 0.02
- Stochastic Oscillator
- DNTH 79.92
- RPAY 36.36
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About RPAY Repay Holdings Corporation
Repay Holdings Corp is engaged in providing integrated payment processing solutions to verticals that have transaction processing needs. It allows customers to pay through Mobile App, Text, Interactive Voice Response, Virtual Terminal, Hosted Payment Page and Online Customer Portal among others. It operates in two segment, Consumer Payment and Business Payments.